Aromics and Iproteos present their projects at 16th Healthcare Investment Forum Blog Post

Aromics and Iproteos, based at the Barcelona Science Park, have been selected to present their innovation projects at 16th Healthcare Investment Forum, which took place on 9th March at the meeting room of the Barcelona Medical Association (COMB). The workshop, organised by Biocat, Esade BAN, Barcelona Activa and COMB, aims to create a meeting point for companies in the healthcare sector and investors who might be interested in funding their idea or product. Since 2009, this initiative has helped lunch over 100 companies following a selection process that evaluated about 400 projects.

 

Minoryx Therapeutics and Palobiofarma receive the 2016 Biosuccess Award Blog Post

The Catalan Association of Biotechnology Companies (CataloniaBio) has recognized with the Biosuccess Award of the Year two companies associated with the Barcelona Science Park (PCB): Minoryx Therapeutics, which has just finished setting up their lab facilities at PCB, and Palobiofarma, which was based at the Parc from 2010 to 2013. The award giving ceremony was held yesterday at Palau de Pedralbes under his winter networking event CataloniaBio Gala Dinner, which this year coincided with the 10th anniversary and gathered more than 250 entrepreneurs, investors, researchers and professionals from the fields of the life sciences and health. 

 

PCB presents the BATX2LAB awards Blog Post

Yesterday, Wednesday 9th March, the Barcelona Science Park organized the awards ceremony of the best research works of the BATX2LAB program –a project fostered as part of its program ‘Research in Society‘–, which this year has been organized with the support of the Municipal Institute of Education of the Barcelona City Council (IMEB). The event took place at the Dolors Aleu Hall at PCB bringing together more than 100 attendees.

 

The adventure of bioentrepreneurship: Keys to success Blog Post

Three entities located in the Barcelona Science Park (PCB) –Bosch i Gimpera Foundation (FBG), Biocat and CataloniaBio– are organizing jointly the Association of Biotechnologists of Catalonia and Association of Biotechnologists of Catalonia, the sixth edition of the course ‘Keys to bioentrepreneurship‘, with support from Dr. Antoni Esteve Foundation. This course, that comprised of four sessions which will be held on 3,10,17 and 24 May, gives the participants first-hand access to the personal experience of the top bioentrepreneurs in the BioRegion of Catalonia, they are the extraordinary people who are rising innovative and international companies. 

 

Esteve reaffirms its commitment to open innovation to develop a platform of gene therapy projects Blog Post

Esteve strengthens its Gene Therapy Platform with two new therapies for Sanfilippo B (EGT-201) and Hunter (EGT-301) syndromes, both developed in collaboration with the Center for Animal Biotechnology and Gene Therapy (CBATEG) of the Universitat Autónoma de Barcelona (UAB). These two new projects join the leading program for the treatment of Sanfilippo A (EGT-101), whose clinical trial will start in late 2016. On Setember 2012, Esteve has moved its Centre for Drug Research and Development to the Barcelona Science Park (PCB) in an attempt to shorten development time and speed up the arrival to market of innovative new drugs. 

 

Jordi Naval: “I think both researchers and companies should expand their scope of vision and ask themselves where they are headed” Blog Post

Jordi Naval takes over the management of Fundació Bosch i Gimpera (FBG) with a clear objective: building a climate of trust and interaction among researchers, investors and the productive fabric. A very ambitious challenge that Naval faces with the skill and resolution that his double ‘expertise’ as both, a scientist and entrepreneur, has given him.

 

IRB Barcelona researcher Benjamí Oller wins one of the ‘Premis Pioner 2015’ Blog Post

The young scientist Benjamí Oller, who recently defended his PhD thesis, done in Prof. Ernest Giralt’s lab at the Institute for Research in Biomedicine (IRB Barcelona), has been awarded one of the five ‘Premis Pioner 2015‘ (Pioneer Prizes 2015), which are presented by the CERCA Institute –an organisation belonging to the Government of Catalonia– in order to recognize to recent doctorates that orient his research to obtain industrial or commercial results. 
 

Ignasi Belda: “We are the only service provider in computational chemistry with a presence in five countries” Blog Post

Intelligent Pharma, specializing in computational chemistry services for the pharmaceutical and biotechnological industries, recently opened a new office in Munich (Germany). It is the fifth international office that the company has set up in the same number of years. The company also recently received a capital injection of 550,000 euros from the Avanza 2 program from the Spanish Ministry of Industry, Energy and Tourism, and the Torres Quevedo call from the Ministry of Economy and Competitiveness.